was continued for 2 h. Then the reaction was quenched with
water (200 ml) and evaporated. Water (50 ml) and diethyl ether
(50 ml) were added, and extraction with diethyl ether (5 × 50
ml), drying (MgSO4) of the combined organic phases and
evaporation gave 234 mg (98%) of the desired product as a light
green solid.
111.1, 64.2, 64.1, 63.7, 63.6, 21.4, 18.9, 16.1, 16.0. IR (KBr,
νmax/cmϪ1): 3448, 2984, 1371, 1271, 1176, 1032, 802, 682. MS:
m/z (EI) 477.1359 (Mϩ. C23H28NO6PS requires 477.1375), 477,
258, 168, 99.
In addition the corresponding chloride (E)-3-(N-p-toluene-
sulfonylindol-7-yl)-but-2-en-1-chloride was isolated (6 mg,
0.02 mmol, 3%).
1H NMR (CDCl3) δ 8.42 (d, J = 3.7, 1H), 7.92 (d, J = 3.5,
1H), 7.83 (d, J = 7.6, 1H), 7.42 (t, J = 7.6, 1H), 6.67 (d, J = 7.6,
1H), 6.53 (d, J = 1.2, 1H), 2.57 (d, J = 1.2, 3H). 13C NMR
(CDCl3) δ 159.0, 149.0, 132.5, 127.5, 124.9, 123.4, 122.9, 121.4,
121.1, 110.1, 17.4. IR (KBr, νmax/cmϪ1): 2923, 1664, 1626, 1599,
1448, 1316, 1118, 808. MS: m/z (EI) 183.0676 (Mϩ. C12H9NO
requires 183.0684), 183, 154, 127, 77. Mp: 142–143 ЊC.
1H NMR (CDCl3) δ 7.63 (d, J = 3.7 Hz, 1H), 7.41 (d, J = 8.2
Hz, 2H), 7.40 (dd, J = 7.8, 1.3 Hz 1H), 7.18 (t, J = 7.5 Hz, 1H),
7.11 (d, J = 8.0 Hz, 2H), 7.04 (dd, J = 7.4, 1.3 Hz, 1H), 6.69 (d,
J = 3.7 Hz, 1H), 5.48 (tq, J = 7.7, 1.4 Hz, 1H), 4.26 (d, J = 7.5
Hz, 2H), 2.30 (s, 3H), 2.15 (d, J = 1.2 Hz, 3H).
(E )-1-Acetyloxy-3-(N-benzylindol-7-yl)-but-2-ene
(13b).
(E )-3-(N-p-Toluenesulfonylindol-7-yl)-)-but-2-en-1-ol (10c).
Dibal-H (1.2 M in toluene, 6.0 ml, 7.2 mmol) was added
dropwise to a Ϫ78 ЊC solution of 4c in toluene (60 ml), and
the reaction mixture was stirred for 3 h during which the
temperature gradually reached 20 ЊC. The mixture was diluted
with dichloromethane (100 ml) and Rochelle’s salt (sat. 100 ml)
was added. The aqueous layer was extracted with dichloro-
methane (3 × 100 ml) and the combined organic phases were
dried (MgSO4) and evaporated. Column chromatography (ethyl
acetate/hexane 1 : 1) afforded 444 mg (65%) of the desired
product as colourless crystals.
Pyridine (0.090 ml, 1.1 mmol) and acetic anhydride (0.10 ml,
1.0 mmol) were added to a solution of 10b (203 mg, 0.73 mmol)
in dichloromethane (5 ml) and stirred for 24 hours at room
temperature. The reaction mixture was quenched with H2O
(5 ml) and dichloromethane (5 ml), extracted with dichloro-
methane (3 × 10 ml) and the combined organic phases were
dried (MgSO4) and evaporated. Column chromatography (ethyl
acetate/heptane 2 : 3) afforded 210 mg (90%) of the desired
product as a pale brown oil.
1H NMR (CDCl3) δ 7.63 (dd, J = 1.2, 7.9 Hz, 1H), 7.32–7.22
(m, 3H), 7.15–7.07 (m, 2H), 6.86 (dd, J = 1.2, 7.2 Hz, 1H), 6.77
(m, 2H), 6.65 (d, J = 3.2 Hz, 1H), 5.55 (dt, J = 1.5, 6.9 Hz, 1H),
5.48 (br s, 2H), 4.72 (br s, 2H), 2.01 (s, 3H), 1.85 (s, 3H). 13C
NMR (CDCl3) δ 205.5, 170.3, 139.8, 139.5, 131.1, 130.8, 129.3,
128.6, 127.1, 126.2, 124.8, 122.1, 120.0, 119.4, 102.1, 60.8, 51.4,
20.2, 19.0. IR (KBr, νmax/cmϪ1): 3031, 1739, 1420, 1361, 1313,
1231, 1028, 796, 725. MS: m/z (EI) 319.1573 (Mϩ. C21H21NO2
requires 319.1572), 319, 244, 168, 154, 91.
1H NMR (CDCl3) δ 7.60 (d, J = 3.5, 1H), 7.44 (d, J = 8.0,
2H), 7.38 (d, J = 7.7, 1H), 7.18 (t, J = 6.8, 1H), 7.13 (d, J = 8.0,
2H), 7.07 (d, J = 7.4, 1H), 6.68 (d, J = 3.8, 1H), 5.63 (t, J = 8.1,
1H), 4.33 (br s, 1H), 2.31 (s, 3H), 2.12 (s, 3H). 13C NMR
(CDCl3) δ 144.4, 140.6, 134.5, 133.8, 133.3, 132.7, 130.7, 129.3,
126.8, 126.6, 126.5, 124.3, 120.3, 111.6, 59.2, 21.4, 18.4. IR
(KBr, νmax/cmϪ1): 3422, 1369, 1169, 1090, 802, 740, 687. MS:
m/z (EI) 341.1095 (Mϩ. C19H19NO3S requires 341.1086), 341,
186, 168, 154, 91. Mp: 132–133 ЊC.
(E )-1-Acetyloxy-3-(N-p-toluenesulfonylindol-7-yl)-but-2-ene
(13c). Pyridine (0.10 ml, 1.2 mmol) and acetic anhydride
(0.10 ml, 1.1 mmol) were added to a solution of 10c (233 mg,
0.68 mmol) in dichloromethane (10 ml) and stirred for 7 hours
at room temperature. The reaction was quenched with water
(10 ml) and extracted with dichloromethane (3 × 10 ml) and the
combined organic phases were dried (MgSO4) and evaporated
to give 244 mg (93%) of the desired product as a light yellow oil,
which on standing turned into a low melting point solid.
1H NMR (CDCl3) δ 7.65 (d, J = 3.8 Hz, 1H), 7.42 (d, J = 8.4
Hz, 2H), 7.39 (dd, J = 1.3, 7.7 Hz, 1H), 7.17 (t, J = 7.5 Hz, 1H),
7.11 (t, J = 8.1 Hz, 2H), 7.05 (dd, J = 1.3, 7.5 Hz, 1H), 6.70 (d,
J = 3.7 Hz, 1H), 5.43 (tq, J = 6.8, 1.4 Hz, 1H), 4.76 (d, J = 6.9
Hz, 2H), 2.31 (s, 3H), 2.12 (s, 3H), 2.11 (s, 3H). 13C NMR
(CDCl3) δ 171.0, 144.5, 142.5, 135.0, 133.2, 132.5, 130.6, 129.2,
126.7, 126.7, 124.1, 123.0, 122.1, 120.4, 111.1, 61.4, 21.4, 21.0,
18.9. IR (KBr, νmax/cmϪ1): 3448, 1736, 1375, 1233, 1176, 802,
681. MS: m/z (EI) 383.1189 (Mϩ. C21H21NO4S requires
383.1191), 383, 258, 244, 168, 154, 91.
(E )-3-(N-Benzylindol-7-yl)-1-chloro-but-2-ene (11b). Diethyl
chlorophosphate (0.060 ml, 0.40 mmol) was added dropwise to
a 0 ЊC solution of 10b (100 mg, 0.31 mmol) and pyridine
(0.10 ml, 1.2 mmol) in dichloromethane (5 ml), the reaction was
stirred at room temperature for 2 hours. Then the mixture was
diluted with diethyl ether (10 ml) and H2O (10 ml), extracted
with diethyl ether (3 × 10 ml) and dried (MgSO4). Column
chromatography (ethyl acetate/heptane 1 : 1) afforded 71 mg
(77%) of the desired product as a pale brown oil.
1H NMR (CDCl3) δ 7.60 (dd, J = 6.7, 1.2 Hz, 1H), 7.25 (m,
3H), 7.10 (m, 2H), 6.86 (m, 3H), 6.63 (d, J = 3.2 Hz, 1H), 5.63
(dt, J = 1.5, 6.7 Hz, 1H), 5.39 (m, 2H), 4.19 (m, 2H), 1.79 (m,
3H). 13C NMR (CDCl3) δ 140.8, 139.0, 132.7, 130.8, 130.5,
128.8, 127.3, 126.3, 125.6, 122.3, 121.9, 120.3, 119.5, 102.4,
51.9, 40.8, 19.3. IR (KBr, νmax/cmϪ1): 3426, 3030, 2922, 1420,
1314, 1176, 796, 725. MS: m/z (EI) 295.1130 (Mϩ. C19H18ClN
requires 295.1128), 295, 259, 168, 91.
(E )-3-(N-p-Toluenesulfonylindol-7-yl)-but-2-en-1-yl diethyl
phosphate (12c). Pyridine (0.10 ml, 1.2 mmol) and diethyl
chlorophosphate (0.19 ml, 1.3 mmol) were added to a 0 ЊC
solution of 10c in dichloromethane (10 ml). The mixture was
heated to room temperature and stirred for 20 h and quenched
with water (10 ml), extracted with dichloromethane (3 × 10 ml)
and the combined organic phases were dried (MgSO4) and
evaporated. Column chromatography (ethyl acetate/hexane
1 : 1) afforded 260 mg (93%) of the desired product as a
colourless oil.
(E )-3-(N-Benzylindol-7-yl)-1-methoxycarbonyloxy-but-2-ene
(14). Methyl chloroformate (0.20 ml, 2.6 mmol) was added
dropwise to a 0 ЊC solution of 10b (380 mg, 1.37 mmol)
in pyridine (2 ml) and dichloromethane (2 ml). The ice bath
was removed, and stirring was continued at room temperature
for 15 h. Dichloromethane (10 ml) and water (10 ml) were
added, and extraction with dichloromethane (3 × 10 ml), drying
of the combined organic phases (MgSO4), and evaporation
followed by column chromatography (ethyl acetate/hexane 1 : 8)
afforded 341 mg (74%) of the desired product as a colourless
oil.
1H NMR (CDCl3) δ 7.64 (d, J = 3.7 Hz, 1H), 7.41 (d, J = 8.4
Hz, 2H), 7.39 (dd, J = 7.6, 1.4 Hz, 1H), 7.17. (t, J = 7.5 Hz, 1H),
7.10 (d, J = 8.0 Hz, 2H), 7.04 (dd, J = 7.4, 1.3 Hz, 1H), 6.69 (d,
J = 3.8 Hz, 1H), 5.46 (dq, J = 1.4, 6.7 Hz, 1H), 4.75 (t, J = 7.1
Hz, 2H), 4.17 (q, J = 7.1 Hz, 4H), 2.30 (s, 3H), 2.11 (s, 3H), 1.36
(t, J = 7.1 Hz, 6H). 13C NMR (CDCl3) δ 144.0, 142.5, 134.7,
133.1, 132.9, 130.6, 129.3, 126.6, 124.1, 122.6, 122.4, 120.5,
1H NMR (CDCl3) δ 7.65 (dd, J = 1.6, 7.9 Hz, 1H), 7.28 (m,
3H), 6.92 (dd, J = 1.5, 7.4 Hz, 1H), 6.89 (d, J = 5.8 Hz, 2H),
6.66 (d, J = 3.2 Hz, 1H), 5.59 (tq, J = 1.4, 7.0 Hz, 1H), 5.49 (d,
J = 12.7, 2H), 4.79 (d, J = 5.0 Hz, 2H), 3.80 (s, 3H), 1.87 (s, 3H).
13C NMR (CDCl3) δ 156.1, 141.1, 139.1, 132.4, 130.7, 130.4,
129.0, 128.8, 127.4, 126.3, 123.7, 122.5, 120.3, 119.6, 102.5,
O r g . B i o m o l . C h e m . , 2 0 0 4 , 2, 1 4 4 7 – 1 4 5 5
1454